This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ferenci P et al. (2002) Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congress of Gastroenterology, Vienna, 1998. Hepatology 35: 716–721
Strauss E and da Costa MF (1998) The importance of bacterial infections as precipitating factors of chronic hepatic encephalopathy in cirrhosis. Hepatogastroenterology 45: 900–904
Acknowledgements
The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Mullen, K., Howard, R. Is acarbose an effective drug for treating patients with cirrhosis and hepatic encephalopathy?. Nat Rev Gastroenterol Hepatol 2, 264–265 (2005). https://doi.org/10.1038/ncpgasthep0194
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep0194
This article is cited by
-
Therapeutic studies in hepatic encephalopathy
Metabolic Brain Disease (2007)